200 related articles for article (PubMed ID: 25682807)
1. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.
Maeda Y; Kawano Y; Wada Y; Yatsuda J; Motoshima T; Murakami Y; Kikuchi K; Imamura T; Eto M
Oncol Rep; 2015 Apr; 33(4):1844-50. PubMed ID: 25682807
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
3. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
[TBL] [Abstract][Full Text] [Related]
4. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
Kaida T; Nitta H; Kitano Y; Yamamura K; Arima K; Izumi D; Higashi T; Kurashige J; Imai K; Hayashi H; Iwatsuki M; Ishimoto T; Hashimoto D; Yamashita Y; Chikamoto A; Imanura T; Ishiko T; Beppu T; Baba H
Oncotarget; 2016 Dec; 7(51):84798-84809. PubMed ID: 27756879
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
Imamura R; Kitagawa S; Kubo T; Irie A; Kariu T; Yoneda M; Kamba T; Imamura T
Prostate; 2021 Feb; 81(3):147-156. PubMed ID: 33368414
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma.
Xi W; Liu L; Wang J; Xia Y; Bai Q; Xiong Y; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Dec; 7(49):80925-80934. PubMed ID: 27821813
[TBL] [Abstract][Full Text] [Related]
7. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
Chen J; Li GQ; Zhang L; Tang M; Cao X; Xu GL; Wu YZ
Cancer Lett; 2018 Jan; 412():30-36. PubMed ID: 29031586
[TBL] [Abstract][Full Text] [Related]
8. Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.
Imamura T; Yamamoto-Ibusuki M; Sueta A; Kubo T; Irie A; Kikuchi K; Kariu T; Iwase H
Breast Cancer; 2016 Nov; 23(6):876-885. PubMed ID: 26494574
[TBL] [Abstract][Full Text] [Related]
9. Functional identification of the stable transfection C5aR cell line Molt-4.
Zhang C; Xu R; Wang J; Han G; Chen G; Wang R; Wei H; Shen B; Ma Y; Li Y
Cell Mol Immunol; 2007 Dec; 4(6):461-5. PubMed ID: 18163958
[TBL] [Abstract][Full Text] [Related]
10. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.
Nishiura H; Tokita K; Li Y; Harada K; Woodruff TM; Taylor SM; Nsiama TK; Nishino N; Yamamoto T
Apoptosis; 2010 Aug; 15(8):966-81. PubMed ID: 20473571
[TBL] [Abstract][Full Text] [Related]
11. PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment.
Saito K; Iioka H; Maruyama S; Sumardika IW; Sakaguchi M; Kondo E
Neoplasia; 2019 Dec; 21(12):1121-1132. PubMed ID: 31759250
[TBL] [Abstract][Full Text] [Related]
12. Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes.
Nitta H; Shimose T; Emi Y; Imamura T; Ohnishi K; Kusumoto T; Yamamoto M; Fukuzawa K; Takahashi I; Higashi H; Tsuji A; Akagi Y; Oki E; Maehara Y; Baba H;
Med Oncol; 2016 Nov; 33(11):118. PubMed ID: 27688239
[TBL] [Abstract][Full Text] [Related]
13. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
Chen J; Sun ZH; Chen LY; Xu F; Zhao YP; Li GQ; Tang M; Li Y; Zheng QY; Wang SF; Yang XH; Wu YZ; Xu GL
Aging (Albany NY); 2020 Jul; 12(14):14285-14299. PubMed ID: 32669478
[TBL] [Abstract][Full Text] [Related]
14. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
[TBL] [Abstract][Full Text] [Related]
15. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
[TBL] [Abstract][Full Text] [Related]
18. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
19. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.
Nishiura H; Zhao R; Yamamoto T
J Biochem; 2011 Sep; 150(3):271-7. PubMed ID: 21613290
[TBL] [Abstract][Full Text] [Related]
20. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
